PROZAC WEEKLY
LOE ApproachingNDAORALCAPSULE, DELAYED REL PELLETS
Approved
Feb 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 7h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PROZAC WEEKLY is a delayed-release oral capsule formulation of fluoxetine, a selective serotonin reuptake inhibitor (SSRI) approved in 2001. The weekly dosing regimen improves patient adherence for depression and other psychiatric conditions. It works by inhibiting serotonin reuptake in the central nervous system, thereby increasing serotonin availability.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure; team size likely stable or contracting as patent expiration nears.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PROZAC WEEKLY currently has zero linked job openings, reflecting its mature lifecycle and approaching loss of exclusivity. Career opportunities on this asset are limited and focused on defending market share or managing transition; professionals seeking growth should prioritize newer Eli Lilly assets or competitors' novel therapies.
Brand ManagerField Sales Representative
Worked on PROZAC WEEKLY at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.